Background {#Sec1}
==========

Preterm infants are at greater risk of developing anemia in comparison to full-term newborns, especially when admitted to an intensive care unit \[[@CR1], [@CR2]\]. Red blood cell (RBC) transfusions are one of the most employed strategies to correct anemia in preterm infants and have been associated with adverse health conditions and death, especially among preterm infants \[[@CR3]--[@CR6]\].

Understanding the events that increase the likelihood of RBC transfusions can contribute to the rational use of blood products in very low birth weight infants. Literature reports that RBC transfusions in preterm neonates are associated with clinical severity, phlebotomy blood loss and use of liberal criteria for the indication of transfusions. Among 640 newborns with a mean birth weight of 880 g and gestational age of 26 weeks, Fabres et al. found that 85 % of them received at least one red blood cell transfusion and that the transfusion volume was associated with birth weight, gestational age, age at first transfusion and the use of inotropic drugs \[[@CR7]\]. Analyzing 147 newborns with a gestational age of 23.6 to 35.7 weeks and a birth weight of 460 to 1495 g, Mimica et al. found that number of transfusions was associated with birth weight, phlebotomy blood loss, duration of mechanical ventilation, peri-intraventricular hemorrhage and the use of liberal RBC transfusion guidelines. Every 10 mL/kg of blood lost increased the number of transfusions by 0.66; every 10 days on mechanical ventilation increased the number of transfusion by 0.59; and the adoption of liberal criteria increased this number by 0.55 \[[@CR1]\]. A multicenter study carried out in seven neonatal units found that phlebotomy blood loss of 10 mL/kg increased the number of RBC transfusions by 27 % (95 % confidence interval: 23 to 30 %).

In this context, the aim of the present study was to analyze the frequency of red blood cell transfusions in very-low-birth-weight preterm infants and factors associated with this procedure in neonatal intensive care units in Brazil.

Methods {#Sec2}
=======

Data collected prospectively from 16 neonatal intensive care units at university hospitals located in seven states in Brazil were analyzed for this study. At each unit, clinical maternal and neonatal data considered essential to improvements in the quality of clinical care were routinely collected using a specific chart. At the time of the data collection for this study, delayed cord clamping or cord milking was not a routine practice at these neonatal units. Each unit was identified with a different letter of the alphabet (A to P).

The research project was approved by the Research Ethics Committee of each of the 16 network units (Research Ethics Committee of Instituto Fernandes Figueira - *Fundação Oswaldo Cruz*, Universidade Federal de São Paulo, Universidade de São Paulo, Universidade de Campinas, Universidade Federal do Rio Grande do Sul, Universidade de São Paulo, Ribeirão Preto, Universidade Estadual Paulista Júlio de Mesquita Filho, Pontifícia Universidade Católica do Rio Grande do Sul, Universidade Estadual de Londrina, Instituto de Medicina Integral Professor Fernando Figueira, Universidade Federal de Uberlândia, Universidade do Estado de Rio de Janeiro, Universidade Federal do Maranhão, Universidade Federal de Minas Gerais, Faculdade de Ciências Médicas de Minas Gerais). The Research Ethics Committee of Instituto Fernandes Figueira - *Fundação Oswaldo Cruz*, Rio de Janeiro was the leading center for database evaluation in the network (CAAE: \# 12244913.2.0000.5505). Since data was obtained from a prospective database of all infants born in the Brazilian Network on Neonatal Research in the study period, informed consent was not obtained from participants because it is not required according to Brazilian regulations and IRB approval. The data were used for the analysis of transfusion frequencies and factors associated with the indication for RBC transfusions in very-low-birth-weight newborns. The inclusion criteria were gestational age 22 to 36.9 weeks, birth weight \< 1500 g and births occurring in the 16 neonatal units of the Brazilian Network on Neonatal Research. Infants with malformations and those who died in the first 12 h of life were excluded from the study.

The following factors were investigated: mother's clinical and obstetric history; birth conditions; sex; gestational age (calculated from the best obstetric estimate or by the neonatal evaluation) \[[@CR8]\]; adequacy of birth weight to gestational age \[[@CR9]\]; Apgar scores; clinical severity in the first 12 h of life based on the Score for Neonatal Acute Physiology, Perinatal Extension, Version II (SNAPPE II) \[[@CR10]\]; neonatal morbidity; and RBC transfusions during hospital stay. The following clinical morbidities were analyzed: respiratory distress syndrome \[[@CR11]\]; pulmonary hemorrhage; apnea \[[@CR12]\]; dependence on oxygen at 28 days of life and/or at 36 weeks of corrected gestational age \[[@CR13]\]; patent ductus arteriosus \[[@CR14]\]; clinical sepsis \[[@CR15]\]; necrotizing enterocolitis \[[@CR16]\]; peri-intraventricular hemorrhage (diagnosed by at least one head ultrasound during hospital stay) \[[@CR17]\]; periventricular leukomalacia \[[@CR18]\]; and retinopathy of prematurity according to The International Classification of Retinopathy of Prematurity \[[@CR19]\]. Data were also collected on the use of mechanical ventilation, vasoactive drugs, umbilical catheter placement and parenteral nutrition.

All neonatal units had written guidelines for RBC transfusions based on the clinical condition of the newborn and on the need for respiratory support or surgery (Fig. [1](#Fig1){ref-type="fig"}). Four units employed criteria based on the chronological age of the newborn. At these units, transfusions in the first two weeks were indicated when the hematocrit was lower than 35 to 40 % in the presence of respiratory support or surgery need, symptoms of anemia or hematocrit lower than 25 to 35 % in asymptomatic infants. Beginning in Week 3, RBC transfusions were indicated when the hematocrit was lower than 25 to 30 % in symptomatic infants or if infants needed respiratory support or surgery or hematocrit was lower than 21 % in asymptomatic infants. The transfusion volume ranged from 10 to 20 mL/kg; 47 % of the neonatal units administered 15 mL/kg at each transfusion.Fig. 1Percentage of neonatal units that indicate red blood cell transfusions when hematocrit is lower than 21 %, 24 %, 30 %, 35 %, 40 % or 45 %, according to clinical characteristics of newborns and need for respiratory support or surgery. MV: mechanical ventilation; MAP: mean airway pressure; FiO~2~: inspired oxygen fraction; retic: reticulocytes count

The convenience sample was composed of all very-low-birth-weight newborns who met the eligibility criteria. According to literature \[[@CR20]\], 15 patients are needed for each independent variable in the logistic regression model. Considering the 35 independent variables analyzed in the present study (19 clinical and 16 neonatal units), a minimum of 525 patients was needed for the present study.

Univariate analysis was performed to test the strength of associations between the independent variables and the occurrence of RBC transfusions, with the inclusion of clinical variables considered important to the event. Variables with a p-value \< 0.20 were incorporated in the multiple logistic regression analysis and those with a p-value \< 0.05 remained in the final model. Statistical analysis was performed with the software SPSS 17.0 (*IBM SPSS Statistics,* Somers, NY), considering significant, p \< 0.05.

Results {#Sec3}
=======

A total of 4882 neonates with very-low-birth-weight (gestational age: 22 to 36.9 weeks) were admitted to the 16 neonatal units during the study period. A total of 599 were excluded based on the eligibility criteria. Thus, 4283 were included in the study (mean gestational age: 29.9 ± 2.9 weeks: birth weight: 1084 ± 275 g); 2187 (51.1 %) were male; and 2937 (68.6 %) were delivered by cesarean section. Apgar scores were 5.8 ± 2.5 at the first minute and 8.0 ± 1.7 at the fifth minute. The SNAPPE II score was 24 ± 24. A total of 2330 (54.4 %) required positive-pressure ventilation in the delivery room.

During the hospital stay in the neonatal intensive care unit, the following complications were recorded: respiratory distress syndrome (n = 2755; 64.3 %), pulmonary hemorrhage (n = 262; 6.1 %), persistent arterial duct (n = 1443; 33.7 %), apnea (n = 1826; 42.6 %), oxygen dependence at 28 days of life (n = 1086; 25.4 %), oxygen dependence at a corrected gestational age of 36 weeks (n = 995; 23.2 %), clinical sepsis (n = 2563; 59.8 %), necrotizing enterocolitis (n = 307; 7.2 %), any degree of peri-intraventricular hemorrhage (n = 1101; 25.7 %), grade III or IV intraventricular hemorrhage (n = 325; 7.6 %), periventricular leukomalacia (n = 264; 6.2 %) and retinopathy of prematurity (n = 787; 18.4 %). Moreover, 2615 (61.1 %) neonates were submitted to mechanical ventilation (median duration: 6 days; Q1-Q3: 2-16 days), 2757 (64.4 %) received an umbilical catheter, 465 (10.9 %) received vasoactive drugs and 3802 (88.8 %) received parenteral nutrition (median duration: 11 days; Q1-Q3: 7-17 days). Median stay in the neonatal intensive care unit was 42 days (Q1-Q3: 26-64 days).

A total of 2208 (51.6 %) newborns received RBC transfusions. Table [1](#Tab1){ref-type="table"} displays the frequency of transfusions at each neonatal unit analyzed. Table [2](#Tab2){ref-type="table"} shows the characteristics of the newborns who received transfusions and those who did not.Table 1Number and percentage of infants transfused in each neonatal unitNeonatal unitsIncluded neonatesTransfused neonatesPercentageA1686840.5B88139444.7C24914859.4D1536945.1E30316153.1F2177434.1G33419056.9H22615066.4I26313149.8J1225242.6K34322365.0L22714363.0M2739434.4N18113071.8O1346951.5P21011253.3Total4283220851.6Table 2Clinical characteristics of transfused vs. not transfused infantsTransfused (n = 2208)Non-transfused (n = 2075)*p*Gestational age (weeks)28.8 ± 2.631.1 ± 2.7\<0.001Gestational age \<28 weeks \[n (%)\]798 (36.1 %)230 (11.1 %)\<0.001Birth weight (grams)971 ± 2541205 ± 242\<0.001Birth weight \<1000 grams \[n (%)\]1211 (54.8 %)380 (18.3 %)\<0.0015^th^ minute Apgar \<7 \[n (%)\]428 (19.4 %)184 (8.9 %)\<0.001SNAPPE II (score)30 ± 2218 ± 18\<0.001Respiratory distress syndrome \[n (%)\]1749 (79.2 %)1006 (48.5 %)\<0.001Apnea \[n (%)\]1168 (52.9 %)658 (31.7 %)\<0.001Pulmonary hemorrhage \[n (%)\]216 (9.8 %)46 (2.2 %)\<0.001Patent ductus arteriosus \[n (%)\]955 (43.3 %)488 (23.5 %)\<0.001Clinical sepsis \[n (%)\]1808 (81.9 %)755 (36.4 %)\<0.001Necrotizing enterocolitis \[n (%)\]266 (12.0 %)41 (2.0 %)\<0.001PIVH grade 3-4 \[n (%)\]240 (10.9 %)85 (4.1 %)\<0.001Periventricular leukomalacia \[n (%)\]183 (8.3 %)81 (3.9 %)\<0.001Retinophaty of prematurity \[n (%)\]514 (23.3 %)273 (13.2 %)\<0.001Need for oxygen at 28 days of life \[n (%)\]799 (36.2 %)287 (13.8 %)\<0.001Need for O~2~ therapy at 36 weeks \[n (%)\]485 (22.0 %)153 (7.4 %)\<0.001Use of umbilical catheter \[n (%)\]1677 (76.0 %)1080 (52.0 %)\<0.001Need for mechanical ventilation \[n (%)\]1848 (83.7 %)767 (37.0 %)\<0.001Duration of mechanical ventilation (days)13 ± 193 ± 8\<0.001Need for vasoactive drugs \[n (%)\]328 (14.9 %)119 (5.7 %)\<0.001Use of paraenteral nutrition \[n (%)\]2136 (96.7 %)1666 (80.3 %)\<0.001Duration of hospitalization (days)59 ± 4135 ± 20\<0.001Hospitalization \> 60 days \[n (%)\]1053 (47.7 %)184 (8.9 %)\<0.001Intra-hospital death \[n (%)\]662 (30.0 %)300 (14.5 %)\<0.001*SNAPPE II* Morbidity and mortality risk scores, *PIVH* peri-intraventricular hemorrhage

The univariate logistic regression to analyze factors associated with the use of RBC transfusions is shown in Table [3](#Tab3){ref-type="table"}. Each neonatal unit was compared to Unit F, which had the lowest rate of RBC transfusions (Table [3](#Tab3){ref-type="table"}). Multiple logistic regression analysis was then performed in order to determine the odd ratios for receiving RBC transfusions (Table [4](#Tab4){ref-type="table"}).Table 3Unadjusted odds ratio of receiving RBC transfusions according to infant's characteristics and neonatal unitOR95 % CI*p*Gestational age (weeks)0.7310.713 -- 0.750\<0.001Birth weight \< 1000 grams5.4184.714 -- 6.228\<0.0015^th^ minute Apgar \<72.4722.055 -- 2.973\<0.001SNAPPE II (score)1.0331.029 -- 1.037\<0.001Respiratory distress syndrome4.0493.541 -- 4.630\<0.001Apnea2.4192.135 -- 2.740\<0.001Patent ductus arteriosus2.4792.172 -- 2.828\<0.001Clinical sepsis7.9036.867 -- 9.094\<0.001Necrotizing enterocolitis6.7954.862 -- 9.496\<0.001PIVH grades 3-42.8552.212 -- 3.685\<0.001Need for oxygen at 28 days of life1.6251.502 -- 1.757\<0.001Retinophaty of prematurity2.0031.705 -- 2.353\<0.001Use of umbilical catheter2.9102.555 -- 3.314\<0.001Need for mechanical ventilation8.7547.581 -- 10.109\<0.001Use of vasoactive drugs2.8682.304 -- 3.570\<0.001Need for parenteral nutrition7.8706.009 -- 10.308\<0.001Intra-hospital death2.5342.135 -- 2.740\<0.001Unit M1.0150.697 -- 1.4770.939Unit A1.3410.883 -- 2.0360.169Unit J1.4360.910 -- 2.2640.120Unit B1.5631.146 -- 2.1330.005Unit D1.5871.038 -- 2.4270.033Unit I1.9181.324 -- 2.7780.001Unit O2.0511.321 -- 3.1850.001Unit E2.1761.518 -- 3.118\<0.001Unit P2.2081.495 -- 3.263\<0.001Unit G25501.789 -- 3.635\<0.001Unit C2.8321.941 -- 4.132\<0.001Unit L3.2902.229 -- 4.854\<0.001Unit K3.5912.511 -- 5.136\<0.001Unit H3.8142.573 -- 5.654\<0.001Unit N4.9263.209 -- 7.561\<0.001*SNAPPE II* Morbidity and mortality risk scores, *PIVH* peri-intraventricular hemorrhageTable 4Final model of multiple logistic regression for factors associated with RBC transfusionsORIC 95 %*p*Gestational age (weeks)-1.098-1.151 -- -1.042\<0.001SNAPPE II1.0111.004 -- 1.0170.001Apnea1.6921.339 -- 2.138\<0.001Pulmonary hemorrhage2.6481.740 -- 4.031\<0.001Clinical sepsis3.2172.553 - 4.054\<0.001PIVH grades 3-41.6421.046 -2.5760.031Necrotizing enterocolitis3.8042.258 -- 6.407\<0.001Need for oxygen at 28 days of life1.5621.173 -- 2.0810.002Use of umbilical catheter1.8641.352 -- 2.569\<0.001Need for mechanical ventilation2.2711.740 -- 2.966\<0.001Use of parenteral nutrition2.0581.271 -- 3.3320.003Hospitalisation \>60 days5.2864.020 -- 6.949\<0.001Unit B2.2461.156 -- 4.3650.017Unit O2.8221.230 -- 6.4700.014Unit I2.8871.383 -- 6.0260.005Unit P2.9611.365 -- 6.4230.006Unit E4.7902.434 -- 9.427\<0.001Unit H5.6382.729 -- 11.651\<0.001Unit C6.1202.991 -- 12.523\<0.001Unit N6.2482.840 -- 13.740\<0.001Unit L8.1203.934 -- 16.759\<0.001Unit K8.3964.376 -- 16.111\<0.001Unit G8.4344.187 -- 16.989\<0.001Significance of the model p \< 0.001. Final model adjusted for gestacional age, *SNAPPE II* respiratory distress syndrome, apnea, pulmonar hemorrhage, patente ductus arteriosus, clinical sepsis, necrotizing enterocolitis, need for oxygen therapy at 28 days of life, peri-intraventricular hemorrhage grades 3-4 (PIVH 3-4), retinopathy of prematurity, use of umbilical cateter, need for mechanical ventilation, use of parenteral nutrition, hospitalization \> 60 days, and neonatal unit where the neonate was born

Discussion {#Sec4}
==========

Considerable variability among neonatal intensive care units was found regarding the frequency of RBC transfusions. The following factors were associated with indications for transfusions: lower gestational age, higher SNAPPE II score, presence of apnea, pulmonary hemorrhage, clinical sepsis, moderate/severe intraventricular hemorrhage, necrotizing enterocolitis, bronchopulmonary dysplasia, umbilical catheter use, parenteral nutrition, prolonged hospital stay and center. These variables are closely interrelated and, to some extent, reflect the morbidities and procedures often described for very-low-birth-weight newborns. However, the cross-sectional design of this investigation does not allow the determination of cause-and-effect relationships between these variables and the transfusion of RBC \[[@CR21]\].

Variability in the frequency of RBC transfusions is often reported in literature \[[@CR7], [@CR22]--[@CR24]\]. This variability may be due to the increasing survival rate of premature infants with lower gestational ages \[[@CR25]\], but is also likely due to a lack of evidence-based criteria for the indication of transfusions \[[@CR26]\]. Thus, the transfusion rate varies among neonatal units due to the severity of the patients' condition. In the present study, patients with higher SNAPPE II score had higher likelihood of being transfused. SNAPPE II score is related with mortality and morbidity \[[@CR10]\] and may be associated with red blood cell transfusions \[[@CR4]--[@CR7]\]. Kling et al. described a prediction model for transfusion in preterm neonates based on phlebotomy blood loss and clinical severity score, even after adjusting for phlebotomy blood loss \[[@CR27]\].

The restrictiveness of the transfusion guidelines may also contribute to the transfusion rates. A study carried out in 11 countries involving interviews with 1018 neonatologists found that only 51.1 % of the neonatal units have written guidelines for the indication of transfusions \[[@CR28]\].

A number of studies report an increase in adverse health conditions associated with RBC transfusions in premature infants, such as necrotizing enterocolitis \[[@CR5], [@CR29]--[@CR31]\], ventricular hemorrhage \[[@CR3], [@CR29]\] and death \[[@CR4]\]. In a retrospective study involving 417 premature infants with grade I peri-intraventricular hemorrhage, 24 developed grade III hemorrhage and 22 developed grade IV hemorrhage after RBC transfusions. The factors associated with the progression in hemorrhage severity were gestational age (OR: 0.95; 95 % CI: 0.92 to 0.98) and having received a transfusion (OR: 2.92; 95 % CI: 2.19 to 3.90) \[[@CR3]\]. In a meta-analysis that included retrospective and case-control studies involving 4857 premature infants, Mohamed and Shah found an association between RBC transfusion and the occurrence of necrotizing enterocolitis 48 h following the transfusion. After controlling for confounding factors, the odds of developing enterocolitis was 2.01-fold (95 % CI: 1.61-2.50) greater among the infants that received transfusions in the previous 48 h in comparison to those who had not received transfusions \[[@CR5]\]. Del Vecchio et al. described an association between the reduction of transfusion rates and a lower incidence of bronchopulmonary dysplasia, retinopathy of prematurity and necrotizing enterocolitis \[[@CR32]\].

In the present study, premature newborns who received RBC transfusions during hospital stay had a 3.8-fold greater chance of developing enterocolitis and a 64 % greater chance of also having a diagnosis of grade III to IV hemorrhage in comparison to those who did not receive transfusions. However, it was not possible to establish the temporal relationship between the transfusions and these complications.

In a multicenter study involving tertiary neonatal care units at university hospitals and a total of 1077 premature newborns (gestational age: 23.0 to 36.9 weeks; birth weight: 400 to 1495 g), the relative risk of hospital death was 49 % greater among those who received at least one RBC transfusion in the first 28 days of life in comparison to those who did not receive transfusions, after controlling for confounding factors. Moreover, the relative risk of death after 28 days of life was 89 % greater among newborns who received three or more RBC transfusions during hospital stay in comparison to those who received one or two transfusions \[[@CR4]\]. While this association was not investigated in the present study, it is a cause of concern that half of the newborns analyzed received at least one transfusion.

The use of an umbilical catheter was associated with a greater frequency of RBC transfusions. This association may have been due to the fact that umbilical catheters are employed in premature infants with lower gestational ages and greater clinical severity. However, an umbilical catheter facilitates blood collection for laboratory exams and can lead to greater blood loss, thereby increasing the need for transfusions.

The use of supplementary oxygen at 28 days of life, mechanical ventilation and vasoactive drugs were also associated with the indication for transfusions possibly due to the need for support to improve oxygenation and/or tissue perfusion. In a study by Guillén et al. involving 1018 neonatologists, the authors found that the following variables had the greatest influence on the decision to submit very-low-birth-weight newborns to RBC transfusions: the need for supplementary oxygen (44.7 % of neonatologists), need for respiratory support (44.1 %), postnatal age (36.5 %), number of reticulocytes (32.7 %) and the use of inotropic drugs (30.9 %). These findings suggest that the variables employed in the majority of guidelines for the indication of transfusions are effectively used in the clinical practice \[[@CR28]\].

The variability in transfusion rates among the different neonatal units studied may be explained by the clinical diversity of the premature newborns cared at these services. However, the differences among units persisted even after adjusting for clinical variables considered risk factors for blood transfusions. It is therefore possible that several factors influenced the indication for transfusions at these neonatal units, such as phlebotomy blood loss, differences in the criteria employed for the indication of transfusions, the degree of compliance with existing protocols and other healthcare practices \[[@CR33]\].

A reduction in phlebotomy blood loss is recognized as the most effective measure for diminishing the need for RBC transfusions. Madan et al. showed a 46 % reduction in the number of transfusions in extremely-low-birth-weight preterm infants using a bedside blood gas analyzer, which reduced the volume of blood for laboratory exams \[[@CR34]\]. Mahieu et al. found a reduction in the percentage of premature newborns that received transfusions after adopting of a multi-parameter monitor for laboratory analyses (50.0 % to 38.9 %, p \< 0.05) and a 38 % reduction in the number of transfusions per newborn (2.53 to 1.57; p \< 0.01) \[[@CR35]\].

The adoption of restrictive guidelines for RBC transfusions constitutes another measure for reducing the number transfusions. Venâncio et al. found that the use of restrictive criteria led to a reduction of 16 mL/kg in the volume of RBC transfused per newborn \[[@CR36]\] and an 18 % reduction in the number of transfusions \[[@CR1]\]. These effects are superior to those obtained with erythropoietin \[[@CR2]\]. The practice of delayed cord clamping or cord milking would furher reduce the need for erythrocyte transfusions \[[@CR37]\], but this practice is not routinely stablished in most neonatal units \[[@CR28]\], as well as in the Brazilian neonatal units.

The limitations of our study were its: cross sectional design, lack of data on phlebotomy blood loss and number of transfusions per infant, and absence of data regarding transfusion guideline adherence in each neonatal unit. However the great number of neonates included and the diversity of factors analyzed may have contributed to improve the internal and external validity of this study.

Conclusion {#Sec5}
==========

In conclusion, considerable variability was found among the different neonatal units studied regarding the frequency of RBC transfusions. Moreover, the influence of the center regarding transfusion practices in very-low-birth-weight newborns persisted even after controlling for confounding factors. The demographic and clinical characteristics of the patients, especially those related to clinical severity and the need for invasive procedures, were significantly associated with the indication for RBC transfusions in very-low-birth-weight newborns.
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